| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Biochemical outcome for hormone-naı̈ve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation
|
Merrick, Gregory S
|
|
2002
|
1 |
2 |
p. 95-101
7 p.
|
article
|
| 2 |
Dosimetric characterization of an encapsulated interstitial brachytherapy source of 125I on a tungsten substrate
|
Nath, Ravinder
|
|
2002
|
1 |
2 |
p. 102-109
8 p.
|
article
|
| 3 |
Early-stage endometrial cancer
|
McCormick, Traci C
|
|
2002
|
1 |
2 |
p. 61-65
5 p.
|
article
|
| 4 |
Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy
|
Crook, Juanita
|
|
2002
|
1 |
2 |
p. 66-73
8 p.
|
article
|
| 5 |
Managing nasopharyngeal carcinoma with intracavitary brachytherapy
|
Lee, Nancy
|
|
2002
|
1 |
2 |
p. 74-82
9 p.
|
article
|
| 6 |
Measurements of the dosimetric constants for a new 103Pd brachytherapy source
|
Peterson, Stephen W.
|
|
2002
|
1 |
2 |
p. 110-119
10 p.
|
article
|
| 7 |
Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy
|
Kiteley, Rex A
|
|
2002
|
1 |
2 |
p. 90-94
5 p.
|
article
|
| 8 |
What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms
|
Stock, Richard G
|
|
2002
|
1 |
2 |
p. 83-89
7 p.
|
article
|
Journal description